Summary

The Europe rapid test kit market was valued at US$ 5,244.46 million in 2022 and is expected to reach US$ 7,763.57 million by 2030; it is estimated to record a CAGR of 5.0% from 2022 to 2030.

Strategic Initiatives by Manufacturers Drive Europe Rapid Test Kit Market

Manufacturers in the rapid test kits market emphasize on the adoption of strategies such as innovations, and product launches and approvals to maintain a competitive edge in the market. Such strategic initiatives by companies in the rapid test kits market benefit the overall market.

In 2022, Singapore-based diagnostics manufacturer INEX Innovate, a pioneer in the women's and fetal health sector in Asia, has received a CE mark for OvaCis Rapid Test, its flagship solution for ovarian cancer. By the end of 2022, OvaCis-a first-of-its-kind point-of-care (POCT) test that distinguishes benign from malignant ovarian cysts in an operating room setting-is expected to make its debut in the EU and Southeast Asian markets.

In January 2022, OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic testing as well as sample collection technologies, launched the OraQuick HIV Self-Test, an oral swab-based in-home test for HIV-1 and HIV-2, for the European market. The test is accessible in six European countries: the UK, France, Germany, Italy, Spain, and Portugal.

In 2021, following the issuance of the CE certificate, FUJIFILM Europe GmbH was authorized to apply the CE mark and introduce an antigen test kit for the diagnosis of SARS-CoV-2 infection. The technique being utilized by Fujifilm is called proprietary silver amplification immunochromatography, and it is based on the same technology that is used to amplify the photos to be developed.

In December 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for a virtually guided BinaxNOW COVID-19 Ag Card (by Abbott) rapid test, indicated for the at-home use for detection of COVID-19. BinaxNOW is a widely distributed and one of the most affordable rapid tests, which provides results in minutes.

In July 2020, the FDA granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor Plus System. The new assay generates results in 15 minutes on an easy-to-use, highly portable instrument. The test was meant to improve access to COVID-19 diagnostics by providing real-time results and aiding quick decision-making while the patient is still in the testing facility.

Europe Rapid Test Kit Market Overview

The prevalence of the diabetes in Germany has been increasing significantly. According to the International Diabetes Federation, in 2021 ~62 million people were having diabetes. Moreover, according to the European Center for Disease Prevention and Control report, 8,641 malarial cases were registered in the European Union (EU) in 2019, of which 8,638 (>99%) were confirmed diagnoses. In September 2022, Germany signed an agreement worth US$ 1.34 billion with The Joint United Nations Programme on HIV/AIDS (UNAIDS) aiming to fight AIDS, tuberculosis, and malaria; with this, the country raised its contribution by 30% compared to 2019. Further, as per the endmalaria.org 2020 report, international sources provided 69% of total funding aiming for malaria control and elimination. The total funding for malaria control and elimination accounted for US$ 3.3 billion, including US$ 0.2 billion contributed by Germany. Thus, the rapid test kits market is likely to grow in Germany in the coming years with the rising prevalence of infectious disease such as diabetes, AIDS, tuberculosis, and malaria.

Europe Rapid Test Kit Market Revenue and Forecast to 2030 (US$ Million)

Europe Rapid Test Kit Market Segmentation

The Europe rapid test kit market is segmented based on type, product, technology, application, end user, and country. Based on type, the Europe rapid test kit market is segmented into rapid antigen testing, rapid antibody testing, and others. The rapid antigen testing segment held the largest market share in 2022.

In terms of product, the Europe rapid test kit market is bifurcated into over-the-counter rapid testing kit and professional rapid testing kit. The over-the-counter rapid testing kit segment held a larger market share in 2022.

By technology, the Europe rapid test kit market is segmented into lateral flow assay, solid phase, agglutination, immunospot assay, and cellular component-based. The lateral flow assay segment held the largest market share in 2022.

Based on application, the Europe rapid test kit market is categorized into blood glucose testing, infectious disease testing, pregnancy and fertility, cardiometabolic testing, and others. The blood glucose testing segment held the largest market share in 2022.

In terms of end user, the Europe rapid test kit market is segmented into hospital and clinics, home care, diagnostics centers, and others. The hospital and clinics segment held the largest market share in 2022.

Based on country, the Europe rapid test kit market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe rapid test kit market share in 2022.

F. Hoffmann-La Roche Ltd, Becton Dickinson and Co, ARKRAY Inc, Sysmex Partec GmbH, Fujirebio Europe NV, bioMerieux SA, Cepheid, Meril Life Sciences Pvt Ltd, QIAGEN NV, OraSure Technologies Inc, Guangzhou Wondfo Biotech Co Ltd, Denka Co Ltd, Abbott Laboratories, Trinity Biotech Plc, Premier Medical Corp Pvt Ltd, Bio-Rad Laboratories Inc, Hologic Inc, DiaSorin SpA, and Beckman Coulter Inc are some of the leading players operating in the Europe rapid test kit market.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS

1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Rapid Test Kits Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Genetic and Infectious Diseases
4.1.2 Strategic Initiatives by Manufacturers
4.2 Market Restraints
4.2.1 Uncertainties Related to Accuracy of Results
4.3 Market Opportunities
4.3.1 Increasing Preference for PCR Techniques
4.4 Future Trends
4.4.1 Innovations in Rapid Antigen Tests
4.5 Impact Analysis
5. Rapid Test Kits Market - Europe Market Analysis
5.1 Overview
5.2 Rapid Test Kits Market Revenue (US$ Mn), 2020 - 2030
6. Europe Rapid Test Kits Market Analysis - by Type
6.1 Overview
6.2 Rapid Antigen Testing
6.2.1 Overview
6.2.2 Rapid Antigen Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Rapid Antibody Testing
6.3.1 Overview
6.3.2 Rapid Antibody Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Rapid Test Kits Market Analysis - by Product
7.1 Overview
7.2 Over-the-Counter Rapid Testing Kit
7.2.1 Overview
7.2.2 Over-the-Counter Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Professional Rapid Testing Kit
7.3.1 Overview
7.3.2 Professional Rapid Testing Kit: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Rapid Test Kits Market Analysis - by Technology
8.1 Overview
8.2 Lateral Flow Assay
8.2.1 Overview
8.2.2 Lateral Flow Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Solid Phase
8.3.1 Overview
8.3.2 Solid Phase: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Agglutination
8.4.1 Overview
8.4.2 Agglutination: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Immunospot Assay
8.5.1 Overview
8.5.2 Immunospot Assay: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Cellular-Component Based
8.6.1 Overview
8.6.2 Cellular-Component Based: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Rapid Test Kits Market Analysis - by Application
9.1 Overview
9.2 Blood Glucose Testing
9.2.1 Overview
9.2.2 Blood Glucose Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Infectious Disease Testing
9.3.1 Overview
9.3.2 Infectious Disease Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.3.3 Infectious Disease Testing: Rapid Test Kits Market, by Application - Revenue and Forecast to 2030 (US$ Million)
9.4 Cardiometabolic Testing
9.4.1 Overview
9.4.2 Cardiometabolic Testing: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Pregnancy and Fertility
9.5.1 Overview
9.5.2 Pregnancy and Fertility: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Rapid Test Kits Market Analysis - by End User
10.1 Overview
10.2 Hospital and Clinics
10.2.1 Overview
10.2.2 Hospital and Clinics: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Home-Care
10.4.1 Overview
10.4.2 Home-Care: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11. Europe Rapid Test Kits Market - Country Analysis
11.1 Europe
11.1.1 Europe: Rapid Test Kits Market - Revenue and Forecast Analysis - by Country
11.1.1.1 Germany
11.1.1.1.1 Overview
11.1.1.2 Germany: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 Germany: Rapid Test Kits Market Breakdown, by Type
11.1.1.2.2 Germany: Rapid Test Kits Market Breakdown, by Product
11.1.1.2.3 Germany: Rapid Test Kits Market Breakdown, by Technology
11.1.1.2.4 Germany: Rapid Test Kits Market Breakdown, by Application
11.1.1.2.4.1 Germany: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.2.5 Germany: Rapid Test Kits Market Breakdown, by End User
11.1.1.3 United Kingdom
11.1.1.3.1 Overview
11.1.1.4 United Kingdom: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Type
11.1.1.4.2 United Kingdom: Rapid Test Kits Market Breakdown, by Product
11.1.1.4.3 United Kingdom: Rapid Test Kits Market Breakdown, by Technology
11.1.1.4.4 United Kingdom: Rapid Test Kits Market Breakdown, by Application
11.1.1.4.4.1 United Kingdom: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.4.5 United Kingdom: Rapid Test Kits Market Breakdown, by End User
11.1.1.5 France
11.1.1.5.1 Overview
11.1.1.6 France: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.6.1 France: Rapid Test Kits Market Breakdown, by Type
11.1.1.6.2 France: Rapid Test Kits Market Breakdown, by Product
11.1.1.6.3 France: Rapid Test Kits Market Breakdown, by Technology
11.1.1.6.4 France: Rapid Test Kits Market Breakdown, by Application
11.1.1.6.4.1 France: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.6.5 France: Rapid Test Kits Market Breakdown, by End User
11.1.1.7 Italy
11.1.1.7.1 Overview
11.1.1.8 Italy: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.8.1 Italy: Rapid Test Kits Market Breakdown, by Type
11.1.1.8.2 Italy: Rapid Test Kits Market Breakdown, by Product
11.1.1.8.3 Italy: Rapid Test Kits Market Breakdown, by Technology
11.1.1.8.4 Italy: Rapid Test Kits Market Breakdown, by Application
11.1.1.8.4.1 Italy: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.8.5 Italy: Rapid Test Kits Market Breakdown, by End User
11.1.1.9 Spain
11.1.1.9.1 Overview
11.1.1.10 Spain: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.10.1 Spain: Rapid Test Kits Market Breakdown, by Type
11.1.1.10.2 Spain: Rapid Test Kits Market Breakdown, by Product
11.1.1.10.3 Spain: Rapid Test Kits Market Breakdown, by Technology
11.1.1.10.4 Spain: Rapid Test Kits Market Breakdown, by Application
11.1.1.10.4.1 Spain: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.10.5 Spain: Rapid Test Kits Market Breakdown, by End User
11.1.1.11 Rest of Europe
11.1.1.11.1 Overview
11.1.1.12 Rest of Europe: Rapid Test Kits Market - Revenue and Forecast to 2030 (US$ Million)
11.1.1.12.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Type
11.1.1.12.2 Rest of Europe: Rapid Test Kits Market Breakdown, by Product
11.1.1.12.3 Rest of Europe: Rapid Test Kits Market Breakdown, by Technology
11.1.1.12.4 Rest of Europe: Rapid Test Kits Market Breakdown, by Application
11.1.1.12.4.1 Rest of Europe: Rapid Test Kits Market Breakdown, by Infectious Disease Testing
11.1.1.12.5 Rest of Europe: Rapid Test Kits Market Breakdown, by End User
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Rapid Test Kit Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Becton Dickinson and Co
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 ARKRAY Inc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sysmex Partec GmbH
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Fujirebio Europe NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Cepheid
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Meril Life Sciences Pvt Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 QIAGEN NV
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 OraSure Technologies Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Guangzhou Wondfo Biotech Co Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Denka Co Ltd
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
13.13 Abbott Laboratories
13.13.1 Key Facts
13.13.2 Business Description
13.13.3 Products and Services
13.13.4 Financial Overview
13.13.5 SWOT Analysis
13.13.6 Key Developments
13.14 Trinity Biotech Plc
13.14.1 Key Facts
13.14.2 Business Description
13.14.3 Products and Services
13.14.4 Financial Overview
13.14.5 SWOT Analysis
13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
13.15.1 Key Facts
13.15.2 Business Description
13.15.3 Products and Services
13.15.4 Financial Overview
13.15.5 SWOT Analysis
13.15.6 Key Developments
13.16 Hologic Inc
13.16.1 Key Facts
13.16.2 Business Description
13.16.3 Products and Services
13.16.4 Financial Overview
13.16.5 SWOT Analysis
13.16.6 Key Developments
13.17 DiaSorin SpA
13.17.1 Key Facts
13.17.2 Business Description
13.17.3 Products and Services
13.17.4 Financial Overview
13.17.5 SWOT Analysis
13.17.6 Key Developments
13.18 Premier Medical Corp Pvt Ltd
13.18.1 Key Facts
13.18.2 Business Description
13.18.3 Products and Services
13.18.4 Financial Overview
13.18.5 SWOT Analysis
13.18.6 Key Developments
13.19 Beckman Coulter Inc
13.19.1 Key Facts
13.19.2 Business Description
13.19.3 Products and Services
13.19.4 Financial Overview
13.19.5 SWOT Analysis
13.19.6 Key Developments
14. Appendix
14.1 About The Insight Partners